This data indicated that the percentage of IFN-γ+ and IL-2+ secreted from T cells observed in subsequent experiments was not a result of differences in the percentage of CD4+ and CD8+ T cells among SSc patients with and without anti-Scl-70 antibody and healthy volunteers. This evidence concerns the gene IFNG and systemic sclerosis.